Effects of cyclodextrin in two patients with Niemann-Pick Type C disease.

[1]  W. Brown.  From the editor: What is obesity? , 2013, Journal of clinical lipidology.

[2]  Benny Liu.  Therapeutic potential of cyclodextrins in the treatment of Niemann–Pick type C disease , 2012, Clinical lipidology.

[3]  T. Steck,et al.  Activation Mobilizes the Cholesterol in the Late Endosomes-Lysosomes of Niemann Pick Type C Cells , 2012, PloS one.

[4]  B. Liu,et al.  Unesterified Cholesterol Accumulation in Late Endosomes/Lysosomes Causes Neurodegeneration and Is Prevented by Driving Cholesterol Export from This Compartment , 2011, The Journal of Neuroscience.

[5]  C. Vite,et al.  2-Hydroxypropyl-β-Cyclodextrin Raises Hearing Threshold in Normal Cats and in Cats With Niemann-Pick Type C Disease , 2010, Pediatric Research.

[6]  M. O'Callaghan,et al.  Clinical experience with miglustat therapy in pediatric patients with Niemann-Pick disease type C: a case series. , 2010, Molecular genetics and metabolism.

[7]  F. Maxfield,et al.  Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cells , 2010, Proceedings of the National Academy of Sciences.

[8]  D. Ory,et al.  Chronic Cyclodextrin Treatment of Murine Niemann-Pick C Disease Ameliorates Neuronal Cholesterol and Glycosphingolipid Storage and Disease Progression , 2009, PloS one.

[9]  J. Repa,et al.  Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1−/− mouse , 2009, Proceedings of the National Academy of Sciences.

[10]  M. Vanier.  Niemann-Pick disease type C , 2010, Orphanet journal of rare diseases.

[11]  K. Uekama,et al.  Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. , 1997, Journal of pharmaceutical sciences.

[12]  C. Vite,et al.  2-hydroxypropyl-beta-cyclodextrin raises hearing threshold in normal cats and in cats with Niemann-Pick type C disease. , 2010, Pediatric research.